The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bausch Health Cos (BHC - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Bausch Health Cos is one of 844 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BHC is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BHC's full-year earnings has moved 8.18% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, BHC has returned 31.19% so far this year. At the same time, Medical stocks have gained an average of 2.48%. As we can see, Bausch Health Cos is performing better than its sector in the calendar year.
Looking more specifically, BHC belongs to the Medical - Generic Drugs industry, a group that includes 23 individual stocks and currently sits at #151 in the Zacks Industry Rank. Stocks in this group have lost about 4.74% so far this year, so BHC is performing better this group in terms of year-to-date returns.
BHC will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.